ROCKET PHARMACEUTICALS, INC.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
RCKT$2.39-2.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interest Expense
Interest expense for the three and nine months ended September 30, 2025, and 2024 was related to our financing lease obligation for our Cranbury, NJ facility.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.